Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Tinnitus With Olanzapine: A Randomized Crossover Versus Placebo Study

NCT07190482 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07190482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Tinnitus With Olanzapine: A Randomized Crossover Versus Placebo Study
Lead sponsor
University of Sao Paulo
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2023
Completion date
January 20, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus, tinnitus, subjective